UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 649

Sortiert nach

Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors

European heart journal, 2010-01, Vol.31 (2), p.149-164

2010

Volltextzugriff (PDF)

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

European heart journal, 2011-06, Vol.32 (11), p.1345-1361

2011

Volltextzugriff (PDF)

Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics

European heart journal, 2020-06, Vol.41 (24), p.2304-2312

2020

Volltextzugriff (PDF)

Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

Clinical chemistry (Baltimore, Md.), 2018-07, Vol.64 (7), p.1006-1033

2018

Volltextzugriff (PDF)

Lipoprotein(a) as a cardiovascular risk factor: current status

European heart journal, 2010-12, Vol.31 (23), p.2844-2853

2010

Volltextzugriff (PDF)

LDL Cholesterol: ‘The Times They Are A-Changin’

Clinical chemistry (Baltimore, Md.), 2020-09, Vol.66 (9), p.1136-1139

2020

Volltextzugriff (PDF)

HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events

Clinical chemistry (Baltimore, Md.), 2011-03, Vol.57 (3), p.392-410

2011

Volltextzugriff (PDF)

European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk

European heart journal, 2017-08, Vol.38 (29), p.2245-2255

2017

Volltextzugriff (PDF)

Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy

European heart journal, 2013-11, Vol.34 (41), p.3182-3190

2013

Volltextzugriff (PDF)

Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN

European heart journal cardiovascular imaging, 2014-04, Vol.15 (4), p.380-388

2014

Volltextzugriff (PDF)

Plant sterols and cardiovascular disease: a systematic review and meta-analysis

European heart journal, 2012-02, Vol.33 (4), p.444-451

2012

Volltextzugriff (PDF)

Detailed analysis of peripheral blood natural killer (NK) cells in women with recurrent miscarriage

Human reproduction (Oxford), 2010-01, Vol.25 (1), p.52-58

2010

Volltextzugriff (PDF)

No evidence of neurocognitive adverse events associated with alirocumab treatment in 3340 patients from 14 randomized Phase 2 and 3 controlled trials: a meta-analysis of individual patient data

European heart journal, 2018-02, Vol.39 (5), p.374-381

2018

Volltextzugriff (PDF)

The year in cardiology 2015: prevention

Arquivos brasileiros de cardiologia, 2016-02, Vol.37 (6), p.510-519

2016

Volltextzugriff (PDF)

Metabolic Syndrome Is Associated with Elevated Oxidative Stress and Dysfunctional Dense High-Density Lipoprotein Particles Displaying Impaired Antioxidative Activity

The journal of clinical endocrinology and metabolism, 2004-10, Vol.89 (10), p.4963-4971

2004

Volltextzugriff (PDF)

Septic Shock and Sepsis: A Comparison of Total and Free Plasma Cortisol Levels

The journal of clinical endocrinology and metabolism, 2006-01, Vol.91 (1), p.105-114

2006

Volltextzugriff (PDF)

1 – 25 von 649

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

KollektionOxford Journals 2020 Medicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(640)

Publikationsform

Artikel
(645)
Tagungsberichte
(4)

Sprache

Englisch
(649)
Japanisch
(84)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(406)
Science & Technology
(406)
Humans
(344)
Biological And Medical Sciences
(240)
Female
(206)
Male
(203)
Medical Sciences
(191)
Adult
(137)
Middle Aged
(117)
Aged
(82)
Animals
(77)
Fundamental And Applied Biological Sciences. Psychology
(73)
Infectious Diseases
(66)
Cardiovascular System & Cardiology
(57)
Microbiology
(56)
Risk Factors
(49)
Cardiac & Cardiovascular Systems
(48)
Immunology
(46)
Adolescent
(45)
Neurosciences & Neurology
(37)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics

Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract

Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

Lipoprotein(a) as a cardiovascular risk factor: current status

LDL Cholesterol: ‘The Times They Are A-Changin’

HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events

European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk

Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy

Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN

Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment

2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia

Plant sterols and cardiovascular disease: a systematic review and meta-analysis

Detailed analysis of peripheral blood natural killer (NK) cells in women with recurrent miscarriage

No evidence of neurocognitive adverse events associated with alirocumab treatment in 3340 patients from 14 randomized Phase 2 and 3 controlled trials: a meta-analysis of individual patient data

The year in cardiology 2015: prevention

Metabolic Syndrome Is Associated with Elevated Oxidative Stress and Dysfunctional Dense High-Density Lipoprotein Particles Displaying Impaired Antioxidative Activity

Septic Shock and Sepsis: A Comparison of Total and Free Plasma Cortisol Levels

Aktive Filter

Suchergebnisse filtern